 |
autologous T-cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor |
|---|---|
| Trade Name | |
| Orphan Indication | Primary mediastinal B-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2016-04-20 00:00:00 |
| Sponsor | Kite Pharma, Inc.;2225 Colorado Avenue;Santa Monica, California, 90404 |
